Discovery of ischemia-selective NMDA antagonists reported at ACS by Cambridge NeuroScience March 29, 2000
Neurogen patents new series of compounds that selectively bind to brain GABA-A receptors March 28, 2000
ACS presentation for AMP-397A, a broad-spectrum anticonvulsant with a novel mechanism of action March 27, 2000